HomeECX • ETR
Follow
Epigenomics AG
Previous close
€1.67
Day range
€1.63 - €1.68
Year range
€1.55 - €2.55
Market cap
1.46M EUR
Avg Volume
513.00
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 68.11K | -86.72% |
Operating expense | -2.10M | -132.97% |
Net income | 1.88M | 115.95% |
Net profit margin | 2.76K | 220.15% |
Earnings per share | — | — |
EBITDA | 2.30M | 1,209.36% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.10M | -73.04% |
Total assets | 12.84M | -8.17% |
Total liabilities | 20.86M | 13.95% |
Total equity | -8.02M | — |
Shares outstanding | 853.42K | — |
Price to book | -0.18 | — |
Return on assets | 42.11% | — |
Return on capital | 139.67% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 1.88M | 115.95% |
Cash from operations | 374.00K | 117.03% |
Cash from investing | 24.50K | -94.53% |
Cash from financing | 77.50K | 452.27% |
Net change in cash | 421.00K | 110.91% |
Free cash flow | 692.90K | 94.70% |
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Headquarters
Website
Employees
18
